Ledger.Open graph →
SEC Form D · filed March 26, 2020

E25Bio Inc

Offering
$3.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Irene Bosch · Cambridge, MAExec · DirectorAnn Dewitt · Cambridge, MADirectorBobby B. Herrera · Cambridge, MAExecAnthony Figlia · New York, NYExec · DirectorMichael Mayer · New York, NYDirectorRyan Figlia · New York, NYExecAnand Kumar · Pleasanton, CADirectorAshleigh Rogers · Pleasanton, CAExec · DirectorJohn Steffens · New Haven, CTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗